What is KAL cream and how is it used to treat neuropathic pruritus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

KAL Cream: Topical Compound for Neuropathic Pruritus

KAL cream is a compounded topical formulation containing Ketamine, Amitriptyline, and Lidocaine used to treat neuropathic itch (pruritus) by targeting multiple pain and itch pathways simultaneously.

What KAL Cream Contains

KAL cream is a triple-combination topical agent that combines:

  • Ketamine (NMDA receptor antagonist)
  • Amitriptyline (tricyclic antidepressant)
  • Lidocaine (local anesthetic)

This is a compounded medication, meaning it's custom-made by specialty pharmacies rather than commercially manufactured 1, 2.

How It Works

The three components work synergistically through different mechanisms:

  • Ketamine blocks NMDA receptors involved in central sensitization and chronic pain/itch signaling
  • Amitriptyline inhibits reuptake of serotonin and norepinephrine, modulating pain pathways and providing local anesthetic effects
  • Lidocaine blocks sodium channels to provide direct local anesthesia

This multi-targeted approach addresses the complex neurobiology of neuropathic itch more comprehensively than single agents 3, 4, 5.

Clinical Use and Evidence

KAL cream is primarily used for neuropathic pruritus conditions, particularly:

  • Brachioradial pruritus (BRP)
  • Notalgia paresthetica
  • Other localized neuropathic itch syndromes

A 2024 retrospective study of 64 patients with brachioradial pruritus showed that KAL cream combined with pregabalin produced significant itch reduction, though the study found no statistical difference compared to pregabalin alone 1. However, the combination therapy may be valuable for difficult-to-treat cases.

A 2012 pilot study in radiation dermatitis demonstrated that topical amitriptyline-ketamine-lidocaine significantly reduced multiple neuropathic pain parameters including itchiness, burning, and sensitivity within 30 minutes of application, with good compliance (82%) and minimal toxicity 2.

Application Instructions

Apply KAL cream to affected areas 3 times daily as directed. The cream should be applied directly to the site of neuropathic itch 1, 2.

Side Effects and Precautions

Common adverse effects include:

  • Skin irritation at application site (19% in one study) 2
  • Local burning or stinging initially
  • Potential for systemic absorption with extensive application

Important safety considerations:

  • Use only on intact skin or as directed for radiation dermatitis
  • Limit application area to avoid systemic absorption
  • Monitor for local skin reactions
  • This is an off-label compounded formulation without FDA approval for neuropathic itch 4

Clinical Context

While British Association of Dermatologists guidelines don't specifically mention KAL cream, they do acknowledge that topical tricyclic antidepressants (like amitriptyline) have shown antipruritic effects in double-blind RCTs 6. For neuropathic pruritus specifically, the guidelines recommend referral to specialists for treatment 6.

KAL cream represents a rational combination therapy that addresses the gap between topical and systemic treatments for localized neuropathic itch. It's particularly useful when:

  • Systemic gabapentinoids or antidepressants are contraindicated
  • Itch is localized to specific dermatomes
  • Patients prefer topical over systemic therapy
  • First-line topical agents (menthol, capsaicin) have failed 7, 3

The evidence base remains limited to small studies and retrospective analyses, but clinical experience suggests benefit in carefully selected patients with neuropathic pruritus 1, 2, 4.

References

Research

Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012

Research

Basic mechanisms of itch and advances in clinical management.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.